These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18513618)

  • 1. Women, harm reduction and HIV.
    Pinkham S; Malinowska-Sempruch K
    Reprod Health Matters; 2008 May; 16(31):168-81. PubMed ID: 18513618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers.
    Ayon S; Ndimbii J; Jeneby F; Abdulrahman T; Mlewa O; Wang B; Ragi A; Mburu G
    AIDS Care; 2018 Apr; 30(4):480-487. PubMed ID: 29067855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain.
    Shirley-Beavan S; Roig A; Burke-Shyne N; Daniels C; Csak R
    Harm Reduct J; 2020 Oct; 17(1):78. PubMed ID: 33076931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young people and drugs: next generation of harm reduction.
    Merkinaite S; Grund JP; Frimpong A
    Int J Drug Policy; 2010 Mar; 21(2):112-4. PubMed ID: 20036526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV prevention among female sex workers in Africa.
    Scheibe A; Drame FM; Shannon K
    SAHARA J; 2012; 9(3):167-72. PubMed ID: 23237073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streets, drugs, and the economy of sex in the age of AIDS.
    Weeks MR; Grier M; Romero-Daza N; Puglisi-Vasquez MJ; Singer M
    Women Health; 1998; 27(1-2):205-29. PubMed ID: 9640643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of harm reduction in Central and Eastern Europe and Central Asia.
    Sarang A; Stuikyte R; Bykov R
    Int J Drug Policy; 2007 Mar; 18(2):129-35. PubMed ID: 17689355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-related violence: its scope and relevance.
    El-bushra J; Piza Lopez E
    Focus Gend; 1993 Jun; 1(2):1-9. PubMed ID: 12345210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview.
    Bobrova N; Sarang A; Stuikyte R; Lezhentsev K
    Int J Drug Policy; 2007 Aug; 18(4):313-8. PubMed ID: 17689380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia.
    Bergenstrom A; McLeod R; Sharma M; Mesquita F; Dorabjee J; Atun R; Lewis G; Rao JV
    Int J Drug Policy; 2010 Mar; 21(2):107-9. PubMed ID: 20144859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. People who use drugs, HIV, and human rights.
    Jürgens R; Csete J; Amon JJ; Baral S; Beyrer C
    Lancet; 2010 Aug; 376(9739):475-85. PubMed ID: 20650514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes].
    Trujols J; Iraurgi I; Solà I; Ballesteros J; Siñol N; Batlle F; Pérez de Los Cobos J
    Adicciones; 2010; 22(2):135-40. PubMed ID: 20549148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
    Allen S; Ruiz M; O'Rourke A
    Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.
    Friedman SR; de Jong W; Rossi D; Touzé G; Rockwell R; Des Jarlais DC; Elovich R
    Int J Drug Policy; 2007 Mar; 18(2):107-17. PubMed ID: 17689353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV/AIDS, sexual and reproductive health: intersections and implications for national programmes.
    Berer M
    Health Policy Plan; 2004 Oct; 19 Suppl 1():i62-i70. PubMed ID: 15452016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.